PER
Click for more information
2.38% 8.2¢ percheron therapeutics limited

Ann: ANP to participate in development of DMD Guidance for FDA, page-6

  1. sankaido
    76 Posts.
    lightbulb Created with Sketch. 17
    clock Created with Sketch.
    25/08/21
    15:01
    Post #: 55563470
    Isn't it also the reason why ANP did not need to take a prominent role in the annual conference - just his low-key appearance in just an after-the-event panel ?
    And that this time they may really have other things in store ?
    ANP Price at posting: 17.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢ 		Change
-0.002(2.38%) 		Mkt cap ! $73.92M
Open High Low Value Volume
8.2¢ 8.2¢ 8.1¢ $24.83K 304.8K

Buyers (Bids)

No. Vol. Price($)
1 61071 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 21678 1
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.